Proton pump inhibitors for chronic obstructive pulmonary disease-Reference-Cited by-同舟云学术

Proton pump inhibitors for chronic obstructive pulmonary disease

Published:2020-08-25 Issue:8 Volume:2020 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Kikuchi Shino¹,Imai Hissei²,Tani Yoko³,Tajiri Tomoko⁴,Watanabe Norio⁵

Affiliation:

1. Department of Gastroenterology and Hepatology; Kyoto University Graduate School of Medicine; Kyoto Japan

2. Department of Health Promotion and Human Behavior; Kyoto University Graduate School of Medicine/School of Public Health; Kyoto Japan

3. Department of Respiratory Medicine; Graduate School of Medicine,Osaka City University; Osaka Japan

4. Department of Respiratory Medicine, Allergy and Clinical Immunology; Graduate School of Medical Sciences, Nagoya City University; Nagoya Japan

5. Department of Health Promotion and Human Behavior; Kyoto University School of Public Health; Kyoto Japan

Publisher

Wiley

Subject

Pharmacology (medical)

Reference107 articles.

1. Sasaki T Katsutoshi N Hiroyasu Y Toshihiro N Mutsuo Y The proton pump inhibitor, lansoprazole, reduces frequency of exacerbations in patients with chronic obstructive pulmonary disease Chest 2011 Annual Meeting; 2011 Oct 22-26; Honolulu 2011

2. A randomized, single-blind study of lansoprazole for the prevention of exacerbations of chronic obstructive pulmonary disease in older patients;Sasaki;Journal of the American Geriatrics Society,2009

3. Sasaki T Nakayama K Yasuda H Yoshida M Inoue D Yamaya M A proton pump inhibitor lansoprazole reduces frequency of exacerbations in patients with chronic obstructive pulmonary disease (COPD) American Thoracic Society International Conference; 2008 May 16-21; Toronto 2008

4. Sasaki T Nakayama K Yasuda H Yoshida M Inoue D Yamaya M The proton pump inhibitor, lansoprazole, reduces frequency of exacerbations in patients with chronic obstructive pulmonary disease Chest 2011 Annual Meeting; 2011 Oct 22-26; Honolulu 2011

5. Effect of high-dose omeprazole on airway hyperresponsiveness and pulmonary function in patients with obstructive lung disease;Boeree;Netherlands Journal of Medicine,1995

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extrapulmonary Comorbidities Associated with Chronic Obstructive Pulmonary Disease: A Review;International Journal of Chronic Obstructive Pulmonary Disease;2024-02

2. Proton Pump Inhibitors: Promising Role in the Prophylaxis and Symptom Control of Acute Exacerbations of Chronic Obstructive Pulmonary Disease;Pneumologia;2022-12-01

3. Effectiveness of Proton-Pump Inhibitors in Chronic Obstructive Pulmonary Disease: A Meta-Analysis of Randomized Controlled Trials;Frontiers in Medicine;2022-02-16

4. Proton Pump Inhibitor Therapy for Eosinophilic Esophagitis: History, Mechanisms, Efficacy, and Future Directions;Journal of Asthma and Allergy;2022-02

5. ASSESSMENT OF THE IMPACT OF ANTIREFLUX THERAPY ON THE COURSE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE;Wiadomości Lekarskie;2021